No abstract available
MeSH terms
-
Anti-Infective Agents / adverse effects
-
Anti-Infective Agents / metabolism
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / metabolism
-
Antineoplastic Agents, Phytogenic / adverse effects*
-
Antineoplastic Agents, Phytogenic / metabolism
-
Arylamine N-Acetyltransferase / genetics
-
Asian People
-
Azathioprine / adverse effects*
-
Azathioprine / metabolism
-
Camptothecin / adverse effects
-
Camptothecin / analogs & derivatives*
-
Camptothecin / metabolism
-
Cytidine Deaminase / genetics
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives
-
Deoxycytidine / metabolism
-
Forecasting*
-
Gemcitabine
-
Glucuronosyltransferase / genetics*
-
Humans
-
Irinotecan
-
Mercaptopurine / adverse effects*
-
Mercaptopurine / metabolism
-
Methyltransferases / genetics*
-
Polymorphism, Genetic*
-
Prodrugs / adverse effects*
-
Prodrugs / metabolism
-
Sulfamethoxazole / adverse effects
-
Sulfamethoxazole / metabolism
Substances
-
Anti-Infective Agents
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents, Phytogenic
-
Prodrugs
-
Deoxycytidine
-
Irinotecan
-
Mercaptopurine
-
Methyltransferases
-
thiopurine methyltransferase
-
Arylamine N-Acetyltransferase
-
NAT2 protein, human
-
UGT1A1 enzyme
-
Glucuronosyltransferase
-
Cytidine Deaminase
-
Sulfamethoxazole
-
Azathioprine
-
Camptothecin
-
Gemcitabine